Skip to main content
. 2012 Mar 5;12(1):49–65. doi: 10.1102/1470-7330.2012.0007

Figure 3.

Figure 3

Patient with CA-125 relapse but no clear evidence of recurrence on CT imaging. Fused FDG-PET/CT (a) and accompanying contrast-enhanced CT (b) demonstrate a serosal deposit along a loop of bowel within the stoma (arrow) that is very difficult to appreciate on CT. Repeat imaging after the first cycle of chemotherapy demonstrates a significant reduction in the metabolic activity of the serosal deposit, highly suggestive of a likely responder to treatment.